site stats

Ceo reshef swisa

WebReshef Swisa is the Founder and CEO of EPM Group. Jobs Edit Jobs Section Number of Current Jobs 1 Reshef Swisais the Founder & CEOat EPM Group. EPM Group Founder & CEOSep 2016 Related Hubs Edit Related Hubs Section Recent News and Activity Edit Recent News and Activity Section There is no recent news or activity for this profile. WebReshef Swisa is the Founder and CEO of EPM Group. Jobs. Edit Jobs Section. Number of Current Jobs 1. Reshef Swisa is the Founder & CEO at EPM Group. EPM Group …

A New Standard for International Conventions - Haaretz.com

WebJan 29, 2024 · Forbes shares more about the accomplishments of Dr. Mechoulam and EPM CEO Reshef Swisa. “EPM developed a method to work with the original substances of … WebJul 13, 2024 · According to Prof. Mechoulam, cannabidiolic acid is a much more powerful compound than CBD or THC Prof. Raphael Mechoulam, also known as the "father of cannabis research", revealed his latest discovery, the methyl ester cannabidiolic acid (EPM301) only a few months ago.… bo3 increased ammo mod https://avaroseonline.com

More Potent Than CBD, THC: Dr. Raphael Mechoulam Explains His Latest ...

WebFeb 24, 2024 · Content Biotechinvesting Information Level Of Sale Analytics And Reporting Active Elements Extra News & Evaluation On Incr Lupos Biotech Fresh Dayly – Cbd Make-up Remover 50g The Lengthy Road Ahead Contains Many Regulatory Hurdles Verda Bio plans to perform analysis into the genetics of marijuana vegetation and check the 85 … WebOct 20, 2024 · During a recent, exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as a pharmaceutical drug. Meet EPM301 “EPM developed a method to work with the original substances of cannabis,” the Professor … WebOct 17, 2024 · During a recent, exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as a pharmaceutical drug. Meet EPM301 “EPM developed a method to work with the original substances of cannabis,” the Professor … bo3 injector pc

Reshef Swisa - CEO at EPM Group Inc. - AroundDeal - B2B Contact ...

Category:New Synthetic Molecules Could Transform Cannabis Treatment

Tags:Ceo reshef swisa

Ceo reshef swisa

Dr. Mechoulam’s Latest Cannabinoid Discovery - Bloom Medicinals

WebJan 26, 2024 · The Father of THC just discovered a cannabinoid more potent than THC and CBD Dr. Raphael Mechoulam is one of the world’s most famous doctors, especially in the world of cannabis medicine. He has been given the nickname “Father of THC” and the “Father of cannabis research” because he is renowned for discovering … WebApr 19, 2024 · EPM's CEO, Israeli entrepreneur Reshef Swisa said that cannabis acids are an exciting avenue for new research because, "while the entire industry is working on the …

Ceo reshef swisa

Did you know?

WebJul 17, 2024 · Also, EPM CEO Reshef Swisa said the U.S. Food and Drug Administration has told the company the compound would not be treated as cannabis but as any other drug in development, thereby avoiding the stigma and legal limitations associated with marijuana. ... but it is a semi-synthetic compound,” Swisa said. Research in Japan has … WebMar 30, 2024 · The Jerusalem Post sat down for an interview last week with EPM's CEO, Israeli entrepreneur Reshef Swisa – who teamed up with the scientist 50 years his senior to found EPM in 2024 – and with...

WebThe company was founded in 2024 by Reshef Swisa and Asaf Ohana, in an intergenerational collaboration with Israeli Prize winner and cannabis pioneer Prof. Raphael Mechoulam. Although the pharmaceutical industry and regulatory institutions have …

WebContents. 1 Mechoulam was possibly the most significant academic to shed light on the active principles of cannabis back in the 1960s, when his work at the Weizmann Institute led to the discovery of the human endo-cannabinoid system.. 1.0.1 WebJul 16, 2024 · We took a cannabidiol acid and we stabilized it by a simple chemical procedure, called esterification; then the compound is stable,” explained EPM CEO …

WebReshef Swisa Founder & CEO at EPM Group Inc. Professional Contact. Company Details. Work History. Update Profile View Full Profile. Reshef Swisa's Professional Contact …

http://cbdtelegraph.com/far-more-potent-than-thc-and-cbd-dr-raphael-mechoulam-explains-his-latest-discovery/ bo3 instant crashWebReshef is an Israeli entrepreneur, 40 years old, married and the father of three children, who grew up in Sderot. Reshef has established successful companies in China (!!!) and currently heads... clientservices casimaging.comWebCEO at EPM Group Inc. Reshef Swisa is the CEO at EPM Group Inc. based in United States. Get Reshef Swisas Contact Info client services aston martinWebEPM Group has 1 current employee profile, Founder & CEO Reshef Swisa. Contacts. Edit Contacts Section. Job Department. Search Contacts... Reshef Swisa. Founder & CEO. … clientservices cblpath.comWebAug 3, 2024 · Professor Raphael Mechoulam, also known as the “father of cannabis research,” revealed his latest discovery, cannabidiolic acid methyl ester (EPM301), client services bonhamsWebOct 20, 2024 · During a recent, exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as ... client services boyce and byhumWebJavier HasseSenior ContributorVices A column about cannabis, hemp, CBD and psychedelics. During a recent, exclusive conversation, CEO Reshef Swisa and Dr. … bo3 ion